These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 31720370)

  • 1. Schistosomiasis-associated pulmonary arterial hypertension: survival in endemic area in Brazil.
    Piscoya Roncal CG; Mendes AA; Muniz MTC; de Oliveira SA; do Valle Neto LM; de Vasconcellos Piscoya NA; Góes GHB; Sobral Filho DC; Gomberg-Maitland M
    Int J Cardiol Heart Vasc; 2019 Dec; 25():100373. PubMed ID: 31720370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival in schistosomiasis-associated pulmonary arterial hypertension.
    dos Santos Fernandes CJ; Jardim CV; Hovnanian A; Hoette S; Dias BA; Souza S; Humbert M; Souza R
    J Am Coll Cardiol; 2010 Aug; 56(9):715-20. PubMed ID: 20723801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Demographic and clinical characteristics of pulmonary arterial hypertension caused by schistosomiasis are indistinguishable from other etiologies.
    Mendes AA; Roncal CGP; Oliveira FRA; Albuquerque ES; Góes GHB; Piscoya ICV; Sobral Filho DC
    Rev Soc Bras Med Trop; 2020; 53():e20190418. PubMed ID: 32049203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of the pulmonary hypertension connection equation for survival prediction in pulmonary arterial hypertension.
    Thenappan T; Glassner C; Gomberg-Maitland M
    Chest; 2012 Mar; 141(3):642-650. PubMed ID: 21885728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Schistosomiasis-associated pulmonary arterial hypertension: a systematic review.
    Knafl D; Gerges C; King CH; Humbert M; Bustinduy AL
    Eur Respir Rev; 2020 Mar; 29(155):. PubMed ID: 32024722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contrasting cardiopulmonary responses to incremental exercise in patients with schistosomiasis-associated and idiopathic pulmonary arterial hypertension with similar resting hemodynamic impairment.
    Valois FM; Nery LE; Ramos RP; Ferreira EV; Silva CC; Neder JA; Ota-Arakaki JS
    PLoS One; 2014; 9(2):e87699. PubMed ID: 24498356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of target therapies in schistosomiasis-associated pulmonary arterial hypertension.
    Fernandes CJCS; Dias BA; Jardim CVP; Hovnanian A; Hoette S; Morinaga LK; Souza S; Suesada M; Breda AP; Souza R
    Chest; 2012 Apr; 141(4):923-928. PubMed ID: 22030800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Value of Follow-Up Hemodynamic Variables After Initial Management in Pulmonary Arterial Hypertension.
    Weatherald J; Boucly A; Chemla D; Savale L; Peng M; Jevnikar M; Jaïs X; Taniguchi Y; O'Connell C; Parent F; Sattler C; Hervé P; Simonneau G; Montani D; Humbert M; Adir Y; Sitbon O
    Circulation; 2018 Feb; 137(7):693-704. PubMed ID: 29070502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary artery enlargement in schistosomiasis associated pulmonary arterial hypertension.
    Hoette S; Figueiredo C; Dias B; Alves JL; Gavilanes F; Prada LF; Jasinowodolinski D; Morinaga LT; Jardim C; Fernandes CJ; Souza R
    BMC Pulm Med; 2015 Oct; 15():118. PubMed ID: 26459359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Risk factors for death and the clinical features of different subtypes of patients with pulmonary arterial hypertension related to congenital heart disease].
    Xu ZY; Li QQ; Zhang C; Zhang HS; Gu H
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Apr; 48(4):315-322. PubMed ID: 32370483
    [No Abstract]   [Full Text] [Related]  

  • 11. Characteristics, Long-term Survival, and Risk Assessment of Pediatric Pulmonary Arterial Hypertension in China: Insights From a National Multicenter Prospective Registry.
    Qian Y; Quan R; Chen X; Gu Q; Xiong C; Han H; Zhang G; Chen Y; Yu Z; Tian H; Liu Y; Zhu X; Li S; Zhang C; He J
    Chest; 2023 Jun; 163(6):1531-1542. PubMed ID: 36470418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Schistosomiasis: A neglected cause of pulmonary arterial hypertension in Brazil.
    Bobrovski VG; Pinheiro AL; de-Castro JAL; Rech EB; Zacarkim EV; Dos-S-Reis ES; Eger I
    Curr Probl Cardiol; 2024 Mar; 49(3):102340. PubMed ID: 38103813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TGF beta and IL13 in Schistosomiasis mansoni associated pulmonary arterial hypertension; a descriptive study with comparative groups.
    Ferreira Rde C; Montenegro SM; Domingues AL; Bandeira AP; Silveira CA; Leite LA; Pereira Cde A; Fernandes IM; Mertens AB; Almeida MO
    BMC Infect Dis; 2014 May; 14():282. PubMed ID: 24886277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Progress of researches on schistosomiasis-associated pulmonary arterial hypertension].
    Zhu YH; Cai Y; Jiang YD; Deng WC
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2022 Aug; 34(4):432-437. PubMed ID: 36116938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival in rheumatoid arthritis-associated pulmonary arterial hypertension compared with idiopathic pulmonary arterial hypertension.
    Sadeghi S; Granton JT; Akhavan P; Pasarikovski CR; Roos AM; Thenganatt J; Moric J; Johnson SR
    Respirology; 2015 Apr; 20(3):481-7. PubMed ID: 25583377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival in pulmonary arterial hypertension: a reappraisal of the NIH risk stratification equation.
    Thenappan T; Shah SJ; Rich S; Tian L; Archer SL; Gomberg-Maitland M
    Eur Respir J; 2010 May; 35(5):1079-87. PubMed ID: 20032020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased pulmonary arterial proportional pulse pressure is associated with increased mortality in group 1 pulmonary hypertension.
    Mwansa H; Bilchick KC; Parker AM; Harding W; Ruth B; Kennedy JLW; Mysore M; Kwon Y; Mihalek A; Mazimba S
    Clin Cardiol; 2017 Nov; 40(11):988-992. PubMed ID: 28692753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL).
    Benza RL; Miller DP; Gomberg-Maitland M; Frantz RP; Foreman AJ; Coffey CS; Frost A; Barst RJ; Badesch DB; Elliott CG; Liou TG; McGoon MD
    Circulation; 2010 Jul; 122(2):164-72. PubMed ID: 20585012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of prognosis and associated risk factors in pediatric idiopathic pulmonary arterial hypertension].
    Liu Q; Zhang C; Li QQ; Zhu Y; Zhang D; Zhao WG; Gu H
    Zhonghua Er Ke Za Zhi; 2018 Jan; 56(1):23-28. PubMed ID: 29342993
    [No Abstract]   [Full Text] [Related]  

  • 20. Pulsatile haemodynamic parameters are predictors of survival in paediatric pulmonary arterial hypertension.
    Douwes JM; Roofthooft MT; Bartelds B; Talsma MD; Hillege HL; Berger RM
    Int J Cardiol; 2013 Sep; 168(2):1370-7. PubMed ID: 23340486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.